{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:04:11Z","timestamp":1744344251689,"version":"3.40.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00210-024-03670-y","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T09:28:59Z","timestamp":1732958939000},"page":"5881-5893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic inhibition of proliferation and induction of apoptosis in oral tongue squamous cell carcinoma by mebendazole and paclitaxel via PI3K\/AKT pathway mitigation"],"prefix":"10.1007","volume":"398","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"key":"3670_CR1","doi-asserted-by":"publisher","first-page":"e2300269","DOI":"10.1002\/ardp.202300269","volume":"356","author":"MH Aboutaleb","year":"2023","unstructured":"Aboutaleb MH, El-Gohary NS, Ghabbour HA, El-Kerdawy MM (2023) Design, synthesis, and evaluation of new benzimidazole thiourea derivatives as antitumor agents. Archiv der Pharmazie 356:e2300269. https:\/\/doi.org\/10.1002\/ardp.202300269","journal-title":"Archiv der Pharmazie"},{"key":"3670_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/cbdd.14130","volume":"100","author":"AM Ali","year":"2022","unstructured":"Ali AM, Tawfik SS, Mostafa AS, Massoud MAM (2022) Benzimidazole-based protein kinase inhibitors: current perspectives in targeted cancer therapy. Chem Biol Drug Des 100:656\u2013673. https:\/\/doi.org\/10.1111\/cbdd.14130","journal-title":"Chem Biol Drug Des"},{"key":"3670_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-cellbio-100913-013226","volume":"30","author":"A Ashkenazi","year":"2014","unstructured":"Ashkenazi A, Salvesen G (2014) Regulated cell death: signaling and mechanisms. Annu Rev Cell Dev Biol 30:337\u2013356. https:\/\/doi.org\/10.1146\/annurev-cellbio-100913-013226","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3670_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-4939-3347-1_2","volume":"1395","author":"BC Baguley","year":"2016","unstructured":"Baguley BC (2016) Classical and targeted anticancer drugs: an appraisal of mechanisms of multidrug resistance. Methods Mol Biol (Clifton, N.J.) 1395:19\u201337. https:\/\/doi.org\/10.1007\/978-1-4939-3347-1_2","journal-title":"Methods Mol Biol (Clifton, N.J.)"},{"key":"3670_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0092-8674(93)90508-n","volume":"74","author":"LH Boise","year":"1993","unstructured":"Boise LH, Gonz\u00e1lez-Garc\u00eda M, Postema CE, Ding L, Lindsten T, Turka LA et al (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597\u2013608. https:\/\/doi.org\/10.1016\/0092-8674(93)90508-n","journal-title":"Cell"},{"key":"3670_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567\u2013578. https:\/\/doi.org\/10.1056\/NEJMoa053422","journal-title":"N Engl J Med"},{"key":"3670_CR7","doi-asserted-by":"publisher","first-page":"105451","DOI":"10.1016\/j.oraloncology.2021.105451","volume":"121","author":"A Chamoli","year":"2021","unstructured":"Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK et al (2021) Overview of oral cavity squamous cell carcinoma: risk factors, mechanisms, and diagnostics. Oral Oncol 121:105451. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105451","journal-title":"Oral Oncol"},{"doi-asserted-by":"publisher","unstructured":"Choi HS, Ko YS, Jin H, Kang KM, Ha IB, Jeong H et al (2022) Mebendazole increases anticancer activity of radiotherapy in radiotherapy-resistant triple-negative breast cancer cells by enhancing natural killer cell-mediated cytotoxicity. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms232415493","key":"3670_CR8","DOI":"10.3390\/ijms232415493"},{"key":"3670_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/s0022-2143(98)90018-x","volume":"132","author":"TC Chou","year":"1998","unstructured":"Chou TC (1998) Drug combinations: from laboratory to practice. J Lab Clin Med 132:6\u20138. https:\/\/doi.org\/10.1016\/s0022-2143(98)90018-x","journal-title":"J Lab Clin Med"},{"key":"3670_CR10","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.bbrc.2016.12.025","volume":"482","author":"D Dai","year":"2017","unstructured":"Dai D, Chen H, Tang J, Tang Y (2017) Inhibition of mTOR\/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma. Biochem Biophys Res Commun 482:1259\u20131264. https:\/\/doi.org\/10.1016\/j.bbrc.2016.12.025","journal-title":"Biochem Biophys Res Commun"},{"key":"3670_CR11","doi-asserted-by":"publisher","first-page":"114067","DOI":"10.1016\/j.addr.2021.114067","volume":"180","author":"TJ DePalma","year":"2022","unstructured":"DePalma TJ, Sivakumar H, Skardal A (2022) Strategies for developing complex multi-component in vitro tumor models: highlights in glioblastoma. Adv Drug Deliv Rev 180:114067. https:\/\/doi.org\/10.1016\/j.addr.2021.114067","journal-title":"Adv Drug Deliv Rev"},{"key":"3670_CR12","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/lary.27490","volume":"129","author":"Z Farhood","year":"2019","unstructured":"Farhood Z, Simpson M, Ward GM, Walker RJ, Osazuwa-Peters N (2019) Does anatomic subsite influence oral cavity cancer mortality? A SEER database analysis. Laryngoscope 129:1400\u20131406. https:\/\/doi.org\/10.1002\/lary.27490","journal-title":"Laryngoscope"},{"key":"3670_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12935-022-02676-x","volume":"22","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, NoieAlamdari A, NoeeAlamdari Y, Abak A, Hussen BM, Taheri M et al (2022) Role of PI3K\/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers. Cancer Cell Int 22:254. https:\/\/doi.org\/10.1186\/s12935-022-02676-x","journal-title":"Cancer Cell Int"},{"key":"3670_CR14","doi-asserted-by":"publisher","first-page":"17407","DOI":"10.18632\/aging.203232","volume":"13","author":"L Huang","year":"2021","unstructured":"Huang L, Zhao L, Zhang J, He F, Wang H, Liu Q et al (2021) Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways. Aging 13:17407\u201317427. https:\/\/doi.org\/10.18632\/aging.203232","journal-title":"Aging"},{"issue":"Suppl 1","key":"3670_CR15","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1007\/s12105-012-0368-1","volume":"6","author":"T Isayeva","year":"2012","unstructured":"Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M (2012) Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol 6(Suppl 1):S104-120. https:\/\/doi.org\/10.1007\/s12105-012-0368-1","journal-title":"Head Neck Pathol"},{"key":"3670_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41199-018-0030-z","volume":"3","author":"K Jung","year":"2018","unstructured":"Jung K, Kang H, Mehra R (2018) Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC). Cancers Head Neck 3:3. https:\/\/doi.org\/10.1186\/s41199-018-0030-z","journal-title":"Cancers Head Neck"},{"key":"3670_CR17","first-page":"3976","volume":"53","author":"SH Kaufmann","year":"1993","unstructured":"Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Can Res 53:3976\u20133985","journal-title":"Can Res"},{"doi-asserted-by":"publisher","unstructured":"Kim JH, Lee KW, Ahn DG, Oh KY, Yoon HJ (2023) Clinical significance of L1CAM expression and its biological role in the progression of oral squamous cell carcinoma. Oncol Rep 49. https:\/\/doi.org\/10.3892\/or.2023.8504","key":"3670_CR18","DOI":"10.3892\/or.2023.8504"},{"key":"3670_CR19","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.1038\/s41598-020-64748-0","volume":"10","author":"YJ Kim","year":"2020","unstructured":"Kim YJ, Kim JH (2020) Increasing incidence and improving survival of oral tongue squamous cell carcinoma. Sci Rep 10:7877. https:\/\/doi.org\/10.1038\/s41598-020-64748-0","journal-title":"Sci Rep"},{"key":"3670_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12885-017-3876-2","volume":"18","author":"D Kumar","year":"2018","unstructured":"Kumar D, Haldar S, Gorain M, Kumar S, Mulani FA, Yadav AS et al (2018) Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K\/Akt pathway. BMC Cancer 18:52. https:\/\/doi.org\/10.1186\/s12885-017-3876-2","journal-title":"BMC Cancer"},{"key":"3670_CR21","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/vco.12288","volume":"15","author":"SR Lai","year":"2017","unstructured":"Lai SR, Castello SA, Robinson AC, Koehler JW (2017) In vitro anti-tubulin effects of mebendazole and fenbendazole on canine glioma cells. Vet Comp Oncol 15:1445\u20131454. https:\/\/doi.org\/10.1111\/vco.12288","journal-title":"Vet Comp Oncol"},{"key":"3670_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s0092-8674(00)80434-1","volume":"91","author":"P Li","year":"1997","unstructured":"Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al (1997) Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479\u2013489. https:\/\/doi.org\/10.1016\/s0092-8674(00)80434-1","journal-title":"Cell"},{"key":"3670_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1158\/2159-8290.Cd-13-0103","volume":"3","author":"VW Lui","year":"2013","unstructured":"Lui VW, Hedberg ML, Li H, Vangara BS, Pendleton K, Zeng Y et al (2013) Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Disc 3:761\u2013769. https:\/\/doi.org\/10.1158\/2159-8290.Cd-13-0103","journal-title":"Cancer Disc"},{"key":"3670_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.7150\/jca.88555","volume":"15","author":"L Ma","year":"2024","unstructured":"Ma L, Huang K, Zhang H, Kim E, Kim H, Liu Z et al (2024) Imatinib inhibits oral squamous cell carcinoma by suppressing the PI3K\/AKT\/mTOR signaling pathway. J Cancer 15:659\u2013670. https:\/\/doi.org\/10.7150\/jca.88555","journal-title":"J Cancer"},{"key":"3670_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev-med-062913-051343","volume":"67","author":"IA Mayer","year":"2016","unstructured":"Mayer IA, Arteaga CL (2016) The PI3K\/AKT pathway as a target for cancer treatment. Annu Rev Med 67:11\u201328. https:\/\/doi.org\/10.1146\/annurev-med-062913-051343","journal-title":"Annu Rev Med"},{"doi-asserted-by":"publisher","unstructured":"McIlwain DR, Berger T, Mak TW (2015) Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 7. https:\/\/doi.org\/10.1101\/cshperspect.a026716","key":"3670_CR26","DOI":"10.1101\/cshperspect.a026716"},{"doi-asserted-by":"publisher","unstructured":"Meco D, Attin\u00e0 G, Mastrangelo S, Navarra P, Ruggiero A (2023) Emerging perspectives on the antiparasitic mebendazole as a repurposed drug for the treatment of brain cancers. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24021334","key":"3670_CR27","DOI":"10.3390\/ijms24021334"},{"key":"3670_CR28","doi-asserted-by":"publisher","first-page":"8202","DOI":"10.1038\/srep08202","volume":"5","author":"M Michaelis","year":"2015","unstructured":"Michaelis M, Agha B, Rothweiler F, L\u00f6schmann N, Voges Y, Mittelbronn M et al (2015) Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen. Sci Rep 5:8202. https:\/\/doi.org\/10.1038\/srep08202","journal-title":"Sci Rep"},{"key":"3670_CR29","first-page":"2963","volume":"8","author":"T Mukhopadhyay","year":"2002","unstructured":"Mukhopadhyay T, Sasaki J, Ramesh R, Roth JA (2002) Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo. Clin Cancer Res 8:2963\u20132969","journal-title":"Clin Cancer Res"},{"key":"3670_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/b978-0-12-407695-2.00007-x","volume":"305","author":"Y Nakayama","year":"2013","unstructured":"Nakayama Y, Yamaguchi N (2013) Role of cyclin B1 levels in DNA damage and DNA damage-induced senescence. Int Rev Cell Mol Biol 305:303\u2013337. https:\/\/doi.org\/10.1016\/b978-0-12-407695-2.00007-x","journal-title":"Int Rev Cell Mol Biol"},{"key":"3670_CR31","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12253-019-00606-3","volume":"26","author":"T Naruse","year":"2020","unstructured":"Naruse T, Yanamoto S, Okuyama K, Ohmori K, Tsuchihashi H, Furukawa K et al (2020) Immunohistochemical study of PD-1\/PD-L1 axis expression in oral tongue squamous cell carcinomas: effect of neoadjuvant chemotherapy on local recurrence. Pathol Oncol Res: POR 26:735\u2013742. https:\/\/doi.org\/10.1007\/s12253-019-00606-3","journal-title":"Pathol Oncol Res: POR"},{"key":"3670_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/leu.2013.350","volume":"28","author":"EM Ocio","year":"2014","unstructured":"Ocio EM, Richardson PG, Rajkumar SV, Palumbo A, Mateos MV, Orlowski R et al (2014) New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG). Leukemia 28:525\u2013542. https:\/\/doi.org\/10.1038\/leu.2013.350","journal-title":"Leukemia"},{"key":"3670_CR33","doi-asserted-by":"publisher","first-page":"33533","DOI":"10.1074\/jbc.273.50.33533","volume":"273","author":"FJ Oliver","year":"1998","unstructured":"Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Murcia JM (1998) Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 273:33533\u201333539. https:\/\/doi.org\/10.1074\/jbc.273.50.33533","journal-title":"J Biol Chem"},{"key":"3670_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3332\/ecancer.2014.443","volume":"8","author":"P Pantziarka","year":"2014","unstructured":"Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP (2014) Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agent. Ecancermedicalscience 8:443. https:\/\/doi.org\/10.3332\/ecancer.2014.443","journal-title":"Ecancermedicalscience"},{"key":"3670_CR35","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.tiv.2015.08.007","volume":"29","author":"LC Pinto","year":"2015","unstructured":"Pinto LC, Soares BM, Pinheiro Jde J, Riggins GJ, Assump\u00e7\u00e3o PP, Burbano RM et al (2015) The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model. Toxicol In Vitro 29:2038\u20132044. https:\/\/doi.org\/10.1016\/j.tiv.2015.08.007","journal-title":"Toxicol In Vitro"},{"key":"3670_CR36","doi-asserted-by":"publisher","first-page":"128097","DOI":"10.1016\/j.bmcl.2021.128097","volume":"43","author":"B Ren","year":"2021","unstructured":"Ren B, Liu RC, Ji K, Tang JJ, Gao JM (2021) Design, synthesis and in vitro antitumor evaluation of novel pyrazole-benzimidazole derivatives. Bioorg Med Chem Lett 43:128097. https:\/\/doi.org\/10.1016\/j.bmcl.2021.128097","journal-title":"Bioorg Med Chem Lett"},{"key":"3670_CR37","first-page":"1201","volume":"1","author":"J Sasaki","year":"2002","unstructured":"Sasaki J, Ramesh R, Chada S, Gomyo Y, Roth JA, Mukhopadhyay T (2002) The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells. Mol Cancer Ther 1:1201\u20131209","journal-title":"Mol Cancer Ther"},{"key":"3670_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2019.03.002","volume":"451","author":"I Shimomura","year":"2019","unstructured":"Shimomura I, Yokoi A, Kohama I, Kumazaki M, Tada Y, Tatsumi K et al (2019) Drug library screen reveals benzimidazole derivatives as selective cytotoxic agents for KRAS-mutant lung cancer. Cancer Lett 451:11\u201322. https:\/\/doi.org\/10.1016\/j.canlet.2019.03.002","journal-title":"Cancer Lett"},{"key":"3670_CR39","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.4110\/in.2020.20.e29","volume":"20","author":"DS Son","year":"2020","unstructured":"Son DS, Lee ES, Adunyah SE (2020) The antitumor potentials of benzimidazole anthelmintics as repurposing drugs. Immune Netw 20:e29. https:\/\/doi.org\/10.4110\/in.2020.20.e29","journal-title":"Immune Netw"},{"key":"3670_CR40","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s11596-023-2813-7","volume":"43","author":"MY Sun","year":"2023","unstructured":"Sun MY, Wang L, Shen ZY (2023) POLE2 regulates apoptosis of oral squamous cell carcinoma cells through the PI3K\/AKT signaling pathway. Curr Med Sci 43:1162\u20131172. https:\/\/doi.org\/10.1007\/s11596-023-2813-7","journal-title":"Curr Med Sci"},{"key":"3670_CR41","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/odi.12206","volume":"21","author":"R Vander Broek","year":"2015","unstructured":"Vander Broek R, Mohan S, Eytan DF, Chen Z, Van Waes C (2015) The PI3K\/Akt\/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies. Oral Dis 21:815\u2013825. https:\/\/doi.org\/10.1111\/odi.12206","journal-title":"Oral Dis"},{"key":"3670_CR42","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00277-005-1065-x","volume":"84","author":"K Vermeulen","year":"2005","unstructured":"Vermeulen K, Van Bockstaele DR, Berneman ZN (2005) Apoptosis: mechanisms and relevance in cancer. Ann Hematol 84:627\u2013639. https:\/\/doi.org\/10.1007\/s00277-005-1065-x","journal-title":"Ann Hematol"},{"key":"3670_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.6004\/jadpro.2020.11.2.1","volume":"11","author":"PH Viale","year":"2020","unstructured":"Viale PH (2020) The American Cancer Society\u2019s facts & figures: 2020 edition. J Adv Pract Oncol 11:135\u2013136. https:\/\/doi.org\/10.6004\/jadpro.2020.11.2.1","journal-title":"J Adv Pract Oncol"},{"key":"3670_CR44","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00784-020-03421-2","volume":"25","author":"M Wunschel","year":"2021","unstructured":"Wunschel M, Neumeier M, Utpatel K, Reichert TE, Ettl T, Spanier G (2021) Staging more important than grading? Evaluation of malignancy grading, depth of invasion, and resection margins in oral squamous cell carcinoma. Clin Oral Investig 25:1169\u20131182. https:\/\/doi.org\/10.1007\/s00784-020-03421-2","journal-title":"Clin Oral Investig"},{"key":"3670_CR45","doi-asserted-by":"publisher","first-page":"12968","DOI":"10.18632\/oncotarget.14673","volume":"8","author":"F Zhang","year":"2017","unstructured":"Zhang F, Li Y, Zhang H, Huang E, Gao L, Luo W et al (2017) Anthelmintic mebendazole enhances cisplatin\u2019s effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC). Oncotarget 8:12968\u201312982. https:\/\/doi.org\/10.18632\/oncotarget.14673","journal-title":"Oncotarget"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03670-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03670-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03670-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:17:43Z","timestamp":1744273063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03670-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3670"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03670-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was approved by Institutional Review Board of The Affiliated Hospital of Chifeng College.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}